Get the SPI Wire

Pasithea Therapeutics Corp.

Nasdaq:KTTA
Annual Meeting

of Shareholders

MEETING DATE

09/09/2026
DEF 14A FILED
08/07/2026
PUBLISHED
08/07/2026 9:15 pm
TIME TO PUBLISH
08/09/2026
METHODOLOGY
approve
EXCHANGE Nasdaq:KTTA· CUSIP 70261F202 · CLASS Common Stock · CIK 0001841330

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

2
FOR
1
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of the director nominees named in this Proxy Statement to hold office until the annual meeting of stockholders in accordance with the class of directors to which such nominees will be assigned
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated Tiago Reis Marques and Lawrence Steinman, and each agreed to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states there were no disagreements or reportable events with Marcum LLP or CBIZ.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Adoption and approval of an amendment to our Second Amended and Restated Certificate of Incorporation, as amended and/or restated from time to time, at the discretion of the Board, to effect a reverse stock split of our issued shares of Common Stock, at a specific ratio, ranging from one-for-two (1:2) to one-for-twenty (1:20), at any time prior to the one-year anniversary date of the Annual Meeting, with the exact ratio to be determined by the Board without further approval or authorization of our stockholders
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the reverse split effectively increases authorized unissued shares that could dilute voting rights.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

effcbb99441b8aac3288d3b9d901b6839144f7b15ef6a9f9947db5e90f7f10d1

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates